What is Major Autohemotherapy (MAH)?
Major autohemotherapy (and countless other ozone therapies) have been in use in Europe for decades. Now these therapies are coming to the U.S. While still considered experimental by insurance companies, these therapies have a large amount of literature and clinical research behind them to show them as being safe.
How is Major Autohemotherapy administered?
The procedure is monitored and administered by our physician on staff and begins with the doctor harnessing about 200mls of your blood into an IV bag. The IV bag will contain an anti-coagulant.
The IV bag with your blood is then infused with ozone and mixed vigorously. The resulting mixture is “super oxygenated” blood that can provide a multitude of benefits.
Finally, the doctor will slowly infuse the bag of “super oxygenated” blood back into your body. The entire process takes about an hour.
What are the potential benefits of Major Autohemotherapy (MAH)?
- Improves blood flow that has been slowed from chronic inflammation and swelling.
- Regulates the immune system. If the immune system is overactive, it will have a calming effect. If it is underactive it will stimulate the immune system.
- Kills viruses, bacteria, and fungus.
- Stimulates the mitochondria (the powerhouses of the cells) to help increase energy.
What conditions can benefit from MAH?
- Chronic Fatigue
Osteo and Rheumatoid Arthritis
Heart and/or Vascular Diseases
Peripheral Artery Disease
Dementia and Cebreal Vascular Diseases
Diabetic Circulatory Disease
Cancer (Complementary concept in oncology)
Asthma and COPD
Hepatitis B and C
Herpes simplex and herpes zoster (shingles)
Eye Diseases especially retinopathies
Infections (viral, bacterial, fungal)
Acute hearing loss (vascular only)
Tinnnitus (vascular only)
Who should NOT get MAH?
Those with a rare condition called Glucose-6-phosphate dehydrogenase deficiency (favism, acute hemolytic anemia).
Those with Hyperthyroidism, if it is not controlled
Those who are pregnant
Those who have leukemia